Stocks and Investing Stocks and Investing
Fri, May 17, 2024
Thu, May 16, 2024

Justin Zelin Initiated (TCRX) at Strong Buy and Held Target at $12 on, May 16th, 2024


Published on 2024-10-28 11:26:23 - WOPRAI, Justin Zelin
  Print publication without navigation


Justin Zelin of BTIG, Initiated "TScan Therapeutics, Inc." (TCRX) at Strong Buy and Held Target at $12 on, May 16th, 2024.

Justin has made no other calls on TCRX in the last 4 months.



There are 4 other peers that have a rating on TCRX. Out of the 4 peers that are also analyzing TCRX, 0 agree with Justin's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Justin


  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $15 on, Tuesday, May 14th, 2024
  • Gil Blum of "Needham" Reiterated at Strong Buy and Held Target at $11 on, Monday, May 13th, 2024
  • David Nierengarten of "Wedbush" Reiterated at Buy and Held Target at $10 on, Tuesday, April 23rd, 2024
  • Peter Lawson of "Barclays" Maintained at Buy with Increased Target to $9 on, Thursday, March 7th, 2024

Contributing Sources
    D885FD0B-4D59-419D-81DE-3DF4BF5AB503
  • support@woprai.com